These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 1358031)

  • 1. [Genetic alterations in the genesis and development of ovarian cancer].
    Okamoto A; Yokoyama S; Terashima Y
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):1971-6. PubMed ID: 1358031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic abnormalities in lung cancer and their prognostic implications].
    Mitsudomi T; Takahashi T
    Gan To Kagaku Ryoho; 1996 Jul; 23(8):990-6. PubMed ID: 8687234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complex characteristics of the alterations of oncogenes HER-2/ERBB-2, HER-1/ERBB-1, HRAS-1, C-MYC and antioncogenes p53, RB1, as well as deletions of loci of chromosome 17 in colon carcinoma].
    Kniazev PG; Imianitov EN; Chernitsa OI; Nikiforova IF; Babenko VI; Bruderliaĭn S; Plutalo OV; Kuz'min AI; Kaboev OK; Berlin IuA
    Mol Biol (Mosk); 1992; 26(5):1134-47. PubMed ID: 1470178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alterations of oncogenes in human cancers].
    Tsuda H; Hirohashi S
    Gan To Kagaku Ryoho; 1993 May; 20(7):977-83. PubMed ID: 8098201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neu.
    Hakim AA; Barry CP; Barnes HJ; Anderson KE; Petitte J; Whitaker R; Lancaster JM; Wenham RM; Carver DK; Turbov J; Berchuck A; Kopelovich L; Rodriguez GC
    Cancer Prev Res (Phila); 2009 Feb; 2(2):114-21. PubMed ID: 19174584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogene patterns in breast and ovarian carcinomas.
    Csókay B; Papp J; Besznyák I; Bösze P; Sárosi Z; Tóth J; Zalay Z; Oláh E
    Eur J Surg Oncol; 1993 Dec; 19(6):593-9. PubMed ID: 7903645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenes in ovarian cancer.
    Berchuck A; Kohler MF; Bast RC
    Hematol Oncol Clin North Am; 1992 Aug; 6(4):813-27. PubMed ID: 1500387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetics of malignant insulinoma.
    Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
    Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular biology in gastric cancer].
    Kikuchi K; Ueda M; Kitajima M
    Gan To Kagaku Ryoho; 1999 Dec; 26(14):2139-46. PubMed ID: 10635296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.
    Yu D; Wolf JK; Scanlon M; Price JE; Hung MC
    Cancer Res; 1993 Feb; 53(4):891-8. PubMed ID: 8094034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of prognostic factors in gynecological cancer examined by molecular biological study].
    Nagai N
    Gan To Kagaku Ryoho; 1996 Jul; 23(8):1004-9. PubMed ID: 8687214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH.
    Wang ZR; Liu W; Smith ST; Parrish RS; Young SR
    Exp Mol Pathol; 1999 Jun; 66(2):140-8. PubMed ID: 10409442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers in the ovary.
    Berchuck A
    J Cell Biochem Suppl; 1995; 23():223-6. PubMed ID: 8747400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alterations of c-myc and c-Ha-ras-1 oncogenes in human ovarian cancer].
    Serova OM; Nikiforova IF; Iurkova LE; Vinokurov VL; Kniazev PG
    Eksp Onkol; 1990; 12(6):47-9. PubMed ID: 2261877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenes and antioncogenes in human breast carcinoma.
    Leslie KO; Howard P
    Pathol Annu; 1992; 27 Pt 1():321-42. PubMed ID: 1346552
    [No Abstract]   [Full Text] [Related]  

  • 17. Familial ovarian cancer.
    Buller RE; Anderson B; Connor JP; Robinson R
    Gynecol Oncol; 1993 Nov; 51(2):160-6. PubMed ID: 7903948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers.
    Rhei E; Bogomolniy F; Federici MG; Maresco DL; Offit K; Robson ME; Saigo PE; Boyd J
    Cancer Res; 1998 Aug; 58(15):3193-6. PubMed ID: 9699640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent advances in gene change of pancreatic cancer].
    Wang YY; Cui QC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):79-82. PubMed ID: 15052782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular biology of human ovarian cancer.
    Chow SN; Chien CH; Chen CT
    Int Surg; 1996; 81(2):152-7. PubMed ID: 8912082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.